Pinnacle Associates’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.51M | Sell |
|
|||||
|
2025
Q1 | $2.95M | Buy |
|
|||||
|
2024
Q4 | $3.57M | Buy |
|
|||||
|
2024
Q3 | $3.42M | Sell |
|
|||||
|
2024
Q2 | $4.81M | Sell |
|
|||||
|
2024
Q1 | $4.34M | Buy |
|
|||||
|
2023
Q4 | $3.42M | Buy |
|
|||||
|
2023
Q3 | $2.96M | Sell |
|
|||||
|
2023
Q2 | $3.59M | Sell |
|
|||||
|
2023
Q1 | $3.59M | Buy |
|
|||||
|
2022
Q4 | $3.03M | Buy |
|
|||||
|
2022
Q3 | $2.15M | Sell |
|
|||||
|
2022
Q2 | $2.5M | Sell |
|
|||||
|
2022
Q1 | $2.69M | Sell |
|
|||||
|
2021
Q4 | $2.87M | Buy |
|
|||||
|
2021
Q3 | $2.24M | Buy |
|
|||||
|
2021
Q2 | $1.4M | Sell |
|
|||||
|
2021
Q1 | $1.14M | Sell |
|
|||||
|
2020
Q4 | $1.34M | Sell |
|
|||||
|
2020
Q3 | $1.49M | Sell |
|
|||||
|
2020
Q2 | $1.42M | Buy |
|
|||||
|
2020
Q1 | $1.29M | Buy |
|
|||||
|
2019
Q4 | $1.23M | Sell |
|
|||||
|
2019
Q3 | $1.15M | Sell |
|
|||||
|
2019
Q2 | $1.15M | Sell |
|
|||||
|
2019
Q1 | $1.23M | Sell |
|
|||||
|
2018
Q4 | $1.14M | Sell |
|
|||||
|
2018
Q3 | $2.98M | Sell |
|
|||||
|
2018
Q2 | $3.13M | Sell |
|
|||||
|
2018
Q1 | $4.02M | Sell |
|
|||||
|
2017
Q4 | $4.7M | Sell |
|
|||||
|
2017
Q3 | $4.36M | Buy |
|
|||||
|
2017
Q2 | $3.68M | Buy |
|
|||||
|
2017
Q1 | $2.81M | Sell |
|
|||||
|
2016
Q4 | $3.17M | Sell |
|
|||||
|
2016
Q3 | $4.05M | Sell |
|
|||||
|
2016
Q2 | $5.99M | Sell |
|
|||||
|
2016
Q1 | $6.33M | Sell |
|
|||||
|
2015
Q4 | $7.01M | Sell |
|
|||||
|
2015
Q3 | $6.63M | Sell |
|
|||||
|
2015
Q2 | $6.75M | Buy |
|
|||||
|
2015
Q1 | $6.35M | Buy |
|
|||||
|
2014
Q4 | $4.84M | Buy |
|
|||||
|
2014
Q3 | $4.56M | Buy |
|
|||||
|
2014
Q2 | $4.31M | Sell |
|
|||||
|
2014
Q1 | $4.41M | Sell |
|
|||||
|
2013
Q4 | $4.15M | Buy |
|
|||||
|
2013
Q3 | $2.93M | Buy |
|
|||||
|
2013
Q2 | $1.57M | Buy |
|